‘The purpose of this micropump is to make it easier for people to receive the results of medical tests when they are in the doctor’s office rather than waiting a couple of days or weeks,’ said bioengineering graduate student Mark Eddings. ‘It also might deliver pain medication or other drugs through a device attached to the skin.’
Bruce Gale, an assistant professor of mechanical engineering at the University of Utah, said an inexpensive, portable and easy-to-manufacture pump should aid development of a lab-on-a-chip, in which ‘we take all the components that would fill a room in a medical lab and put them all down on a chip the size of a credit card.’
Eddings and Gale outlined development of the new micropump in the November 2006 issue of the Journal of Micromechanics and Microengineering, published today.
Gale said labs-on-a-chip are not yet available commercially, although some are getting close. Eddings said possible uses include detection of biowarfare agents, monitoring drug levels in patients, detecting gene mutations, monitoring insulin levels in people with diabetes and many diagnostic tests.
Because liquid can flow slowly through the tiny pump, it also could be used in a drug-delivery device, such as a skin patch with tiny needles, Eddings said.
Gale expects it will take three or four years before the new micropump shows up on commercial lab-on-a-chip devices and in drug-delivery devices.
While a lab-on-a-chip would have hundreds to thousands of micropumps – sets of tiny fluid and air channels and larger chambers in which samples were tested – Eddings and Gale demonstrated their invention by building an array of 10 of the tiny pumps.
They moulded tube-like microchannels, each the width of a human hair, into the top and bottom layers of a three-layered piece of silicone polymer material about the size of a deck of playing cards. The polymer is named polydimethylsiloxane, or PDMS.
‘It’s made out of bathroom caulk,’ Gale said. ‘It is very similar to the clear silicones you’d use to seal your bathtub.’
The card deck-sized array has three layers of rubbery PDMS: a top fluid channel layer, with wells into which blood or other samples are placed, and microchannels through which they can flow toward small chambers; a middle layer, which is a thin, permeable membrane of PDMS designed so that gas can pass through the caulk-like PDMS, while liquid cannot. Finally, there’s a bottom control channel layer, with inlets and tiny channels through which air pressure or a vacuum is applied.
The air pressure or vacuum, respectively, push or pull air through channels in the bottom layer, transmitting pressure or suction through the middle-layer membrane to push or draw fluids through channels in the upper layer.
While an outside air pump or vacuum is needed to run the device, Gale said the membrane is, in effect, the pump because a pump creates a pressure difference, which is what the membrane does to move fluids.
Because gas, not fluid, flows through the middle layer, liquid in the upper-layer microchannels can flow into and fill dead-end channels or chambers without trapping air. That allows the pump to carry samples like blood or fluids with protein or DNA through the microchannels to dead-end chambers that contain chemicals needed for a test.
The outside device to run the lab-on-a-chip – including air pressure or a vacuum to run the micropumps – ‘would be as big your wallet, and the chip would be like a credit card that goes in your wallet,’ Gale said.
Each micropump can produce a flow of up to 200 nanolitres of fluid per minute. ‘If you had a drop on the end of a pin, that would be five times as much fluid as this pump would move in a minute,’ Gale said. ‘In some respects, we are bragging that’s a large flow’ for such a tiny pump. Yet the flow could be slowed considerably if the pump was used to deliver drugs, he added.
The idea of a lab-on-a-chip is to reduce the price and time for lab tests and to conduct them where patients are treated. On such a chip, micropumps replace the large equipment normally used to move blood and other samples through a laboratory test.
The first micropumps were developed 20 years ago, and some are used commercially now, particularly for various sensor devices and for cooling computer chips, Gale said. ‘But almost all the micropumps you find in the last 15 or 20 years are complicated, multilayered devices not conducive to inexpensive manufacturing, and you can’t put a whole bunch of them on a chip,’ he added.
Gale said there are at least 20 categories of micropumps, including ones that move fluids using piston-like devices, magnets, pressure from silicone membranes and electrical charges.
‘Compared with our pump, existing micropumps are difficult to make and more expensive,’ Gale said. ‘They are bulky, and it is difficult to integrate thousands of them simultaneously into a lab-on-a-chip.’
Another advantage of the new micropump is that the mechanical air pressure device or vacuum that powers the pump never contacts blood or other medical samples.
‘Most of these biological fluids are very sensitive,’ Gale said. ‘If you have a medical sample, you don’t want to contaminate it. We’ve removed the complexity of the pump from the microdevice to an external location.’
Eddings said only three or four steps are required to make the new micropump, compared with many steps for existing models.
Gale said he is working to develop a lab-on-a-chip that would test the blood of multiple sclerosis patients to determine if they are developing resistance to a new MS drug.
He also is developing a lab-on-a-chip blood test that would detect genes that affect how quickly various patients break down blood-thinning drugs used to treat heart disease. The test would be used by doctors to decide the right dose for each individual patient, something done now by trial and error, he said.